secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001104659-25-065274
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics shareholders approve reverse stock split authorization at annual meeting
--------------------------------------------------------------------------------

- Stockholders authorized a reverse stock split at ratio between 1:2 and 1:20, with board discretion to set ratio within one year.
- Re-elected directors Edward J. Borkowski, Richard Paolone, Eric Corbett, Manpreet Uppal, and Jack Syage.
- Ratified Machias Gini & O'Connell LLP as independent auditor for fiscal year ending December 31, 2025.
- Advisory vote on named executive officer compensation passed with 415,176 for, 77,434 against (excluding broker non-votes).
- All five proposals were approved; broker non-votes totaled 1,328,218 on director elections and advisory compensation vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925065274/0001104659-25-065274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925065274/tm2519627d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-065274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer